314 patients with non-hodgkin 's lymphomas of low-grade-malignancy ( chronic lymphocytic leukemia , lymphoplasmacytoid , centrocytic , centrocytic , centroblastic-centrocytic lymphoma ) manifested significantly higher median survival times than the 91 patients with non-hodgkin 's lymphomas of high-grade malignancy ( lymphoblastic and immunoblastic lymphoma ) .
C0024305
non-hodgkin 's lymphomas
C0079746
immunoblastic lymphoma